Pepti presents a straightforward starting figure for its injectable Semax listing. The harder questions concern the preparation, the clinical rationale and what follows the first assessment. Use the price to examine the service commitment, while keeping cognitive-performance claims outside that arithmetic. The offer is worth understanding only with its refill schedule, responsible professionals and remaining uncertainties made equally clear.
Advertised starting price
$229 for the displayed injectable offer
Billing basis
Automatic refill subscription; approximately 28-day supply, not a calendar month
CoreAge’s broader care catalog should not be read as confirmation of a Semax offering or a cognitive benefit. The checked lineup did not establish that product. A useful next step is a precise catalog answer and a readable service agreement, especially where renewal and refund wording differ. This review assesses those published limits without turning convenience into a treatment recommendation.
Review scope
Provider brand; target-product availability not verified
An injection listing is not an intranasal offering. The published amount and care description are useful starting information, but the package, actual renewal interval and assigned pharmacy still need confirmation. Judge the offering on the details it supplies and the answers it leaves open, without treating a familiar molecule name as proof of benefit or an individual prescription pathway.
Advertised starting price
$219 per month, as displayed; final checkout interval unverified
The standalone nasal entry is a useful match for a format-specific Semax comparison. Its price is visible, but the total includes review and shipping charges. A nasal listing also needs its own evidence and pharmacy check; it is not proof that the product reproduces a research preparation.
Published product price
$125 for the displayed 15 mL spray; not an established monthly total.
Order charges
A $39 medical review per order; medication billed separately by the pharmacy, with $15 shipping in the reviewed product text.
Verification scope
Public product and fee information reviewed. Assigned pharmacy, individual licenses and final checkout were not independently verified.
First, match the exact molecule and formulation. Ask whether the provider names the clinician and dispensing pharmacy, makes state coverage clear and publishes a full recurring cost. Do not turn an absent detail into a positive assumption.
Read the essential guide before treating similarly named products as equivalent, and keep the current availability distinctions alongside the provider’s claims.
Compare the commitment on equal terms
A monthly price, a 28-day refill and a three-month purchase can produce different payment schedules. Put the actual terms into the cost planner, including the introductory payment, consultation, follow-up and delivery.
What this comparison cannot establish
These are reviews of published information. They do not independently verify the quality of a dispensed product, show that a molecule works for a particular goal or replace a clinician’s assessment. Coverage is limited to the providers reviewed by this publication.
Use the question checklist to ask about missing details before providing payment or health information. Our methodology explains the comparison criteria and the distinction between editorial coverage and partner placements.